Brain dopamine biomarker study for Parkinson's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This study uses a special test to look at dopamine levels in the brain of people with Parkinson's disease. It may help doctors understand the disease better and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a doctor's diagnosis of Parkinson's disease.
- You must be taking a dopamine-related medication (like levodopa) for at least 3 months.
- You should not have certain eye problems (like advanced cataracts, glaucoma, or retinal damage).
- You cannot have a history of seizures triggered by flashing lights.
- You must be able to understand the study and give your own consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether measuring levodopa (a Parkinson medicine) in real time can help better understand Parkinson medication effects. You may be asked to wear/perform study monitoring while taking your usual carbidopa/levodopa tablets.
This study measures blood biomarkers (measurable substances in blood) in people with Parkinson’s at different stages. It may help doctors understand how Parkinson’s changes over time and could guide future testing or treatments.
This study looks for a new blood marker that could help doctors detect Parkinson’s disease earlier. Depending on your diagnosis and treatment status, your blood may be compared with other people’s to see how well the test works.
This trial uses new technology (like sensors or apps) to help diagnose and monitor Parkinson's disease early. Researchers want to see if a simple, widespread healthcare service model can improve care. Both people with Parkinson's and healthy volunteers are needed.
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
This study tests digital devices that may help track Parkinson's symptoms using eye movements and balance. It is designed for people with Parkinson's or related conditions who have trouble with walking (freezing) and can walk for at least 5 minutes.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.